A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal Arteries
Latest Information Update: 13 May 2020
Price :
$35 *
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms LEVANT 2
- Sponsors C R Bard
- 28 Sep 2019 According to a Becton, Dickinson and Company media release, independent analysis data from this and other two trials (LEVANT 1 and LEVANT JAPAN) and the Continued Access cohort of the LEVANT 2 trial were published in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions.
- 28 Sep 2019 According to a Becton, Dickinson and Company media release, independent analysis data from this and other two trials (LEVANT 1 and LEVANT JAPAN) and the Continued Access cohort of the LEVANT 2 trial were presented in in a late-breaking session at Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation.
- 25 Mar 2016 Planned End Date changed from 1 Dec 2016 to 1 Sep 2017, according to ClinicalTrials.gov record.